Search research articles
Contact Us
Filters
Showing results (71-80 of 167) with videos related to
Page
of 17
Sort By:
Plos One
|
July 25, 2024
Definitive radio(chemo)therapy versus upfront surgery in the treatment of HPV-related localized or locally advanced oropharyngeal squamous cell carcinoma
Jérémy Baude, Caroline Guigou, David Thibouw, et al.
Cancers
|
January 23, 2024
Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience
Jérémy Baude, Julie Niogret, Pierre Jacob, et al.
Breast Cancer Research and Treatment
|
May 6, 2025
How can we optimize the surgical management of the axilla in breast cancer since the MonarchE trial?
Clémentine Jankowski, Gilles Houvenaeghel, Celine Renaudeau, et al.
Plos One
|
June 14, 2013
Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells
Hélène Bugaut, Mélanie Bruchard, Hélène Berger, et al.
Oncoimmunology
|
April 9, 2016
Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients
Audrey Hennequin, Valentin Derangère, Romain Boidot, et al.
Blood
|
June 10, 2004
Translocation of the inhibitor of apoptosis protein c-IAP1 from the nucleus to the Golgi in hematopoietic cells undergoing differentiation: a nuclear export signal-mediated event
Stéphanie Plenchette, Séverine Cathelin, Cédric Rébé, et al.
The Journal of Clinical Investigation
|
October 3, 2008
CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer
Stephan Roux, Lionel Apetoh, Fanny Chalmin, et al.
International Journal of Cancer
|
February 26, 2021
ER-/PR+ breast cancer: A distinct entity, which is morphologically and molecularly close to triple-negative breast cancer
Françoise Beltjens, Damien Molly, Aurélie Bertaut, et al.
Oncoimmunology
|
July 7, 2017
Immune classifications with cytotoxic CD8<sup>+</sup> and Th17 infiltrates are predictors of clinical prognosis in glioblastoma
Rachid Madkouri, Coureche Guillaume Kaderbhai, Aurélie Bertaut, et al.
Breast Cancer Research : BCR
|
July 16, 2020
A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer
Claire Bonneau, Antoine Eliès, Yann Kieffer, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 167) with videos related to
Sort By:
Page
of 17
Plos One
|
July 25, 2024
Definitive radio(chemo)therapy versus upfront surgery in the treatment of HPV-related localized or locally advanced oropharyngeal squamous cell carcinoma
Jérémy Baude, Caroline Guigou, David Thibouw, et al.
Cancers
|
January 23, 2024
Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience
Jérémy Baude, Julie Niogret, Pierre Jacob, et al.
Breast Cancer Research and Treatment
|
May 6, 2025
How can we optimize the surgical management of the axilla in breast cancer since the MonarchE trial?
Clémentine Jankowski, Gilles Houvenaeghel, Celine Renaudeau, et al.
Plos One
|
June 14, 2013
Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells
Hélène Bugaut, Mélanie Bruchard, Hélène Berger, et al.
Oncoimmunology
|
April 9, 2016
Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients
Audrey Hennequin, Valentin Derangère, Romain Boidot, et al.
Blood
|
June 10, 2004
Translocation of the inhibitor of apoptosis protein c-IAP1 from the nucleus to the Golgi in hematopoietic cells undergoing differentiation: a nuclear export signal-mediated event
Stéphanie Plenchette, Séverine Cathelin, Cédric Rébé, et al.
The Journal of Clinical Investigation
|
October 3, 2008
CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer
Stephan Roux, Lionel Apetoh, Fanny Chalmin, et al.
International Journal of Cancer
|
February 26, 2021
ER-/PR+ breast cancer: A distinct entity, which is morphologically and molecularly close to triple-negative breast cancer
Françoise Beltjens, Damien Molly, Aurélie Bertaut, et al.
Oncoimmunology
|
July 7, 2017
Immune classifications with cytotoxic CD8<sup>+</sup> and Th17 infiltrates are predictors of clinical prognosis in glioblastoma
Rachid Madkouri, Coureche Guillaume Kaderbhai, Aurélie Bertaut, et al.
Breast Cancer Research : BCR
|
July 16, 2020
A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer
Claire Bonneau, Antoine Eliès, Yann Kieffer, et al.
Page
of 17